Facebook
Twitter
LinkedIn
Forward
CMHC Masterclass On Demand: Frontiers in Interventional Cardiology
This masterclass is designed to explore the latest advances about the most pertinent domains in interventional cardiology. Multidisciplinary experts will present on comprehensive interventional cardiology topics, including pre-procedural evaluation, pharmacological aspects, coronary intervention, peripheral intervention, structural intervention, and more. Each section will include patient cases and expert panel discussion, which will aim to provide practical approaches to patient management and interpret the latest advances to patient care.
Target Audience
US-based healthcare professionals, including primary care clinicians (PCPs), interventional cardiologists, cardiologists, registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals.
Learning Objectives
After completing this activity, the participant should be better able to:
- Integrate advances in the screening, diagnosis, and risk assessment for patients with stable coronary and peripheral artery disease, as well those with acute coronary syndrome
- Outline appropriate pharmacotherapy for patients ACS, CAD, and PAD before and after procedural interventions
- Interpret the results from key clinical trials and evidence for patients with structural and valvular heart disease
- Evaluate the role of pharmacotherapy and evidence-based interventional technologies for the management of atrial fibrillation and arrhythmias
- Discuss advances in pharmacotherapy and endovascular thrombectomy for stroke prevention inpatients with arrhythmias or VTE
- Develop individualized treatment options and interventions for patients with CAD, PAD, ACS, arrhythmias, VTE, and structural/valvular heart disease that incorporate the latest advances in interventional technologies, drugs, and procedures to optimize outcomes
| Deepak L. Bhatt, MD, MPH (Chair) Professor of Medicine, Harvard Medical School Executive Director of Interventional Cardiovascular Programs Brigham and Women's Hospital Heart and Vascular Center Boston, MA | Angela Lowenstern, MD, MHSc Assistant Professor of Medicine Interventional Cardiology Vanderbilt University Medical Center Nashville, TN |
C. Michael Gibson, MS, MD | Christine M. Albert, MD, MPH |
| Dominick J. Angiolillo, MD Professor of Medicine with Tenure Chief of Cardiology Medical Director, UF Health Cardiovascular Center Director, Cardiovascular Research Program Director, Interventional Cardiology Fellowship University of Florida College of Medicine Jacksonville, Florida | Elaine M. Hylek, MD Professor of Medicine Boston University School of Medicine Boston, MA |
Geoffrey Barnes, MD | Gilbert H. Tang, MD Associate Professor of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai Surgical Director, Structural Heart Program, Mount Sinai Health System New York, NY |
| Gregory Piazza, MD Associate Professor of Medicine, Harvard Medical School Physician, Brigham and Women's Hospital Boston, MA | Manesh R. Patel, MD Chief, Division of Clinical Pharmacology Chief, Division of Cardiology Core Faculty in Innovation & Entrepreneurship Duke University Medical Center Durham, NC |
| Marc P. Bonaca, MD Director of Vascular Research Associate Professor of Medicine University of Colorado School of Medicine Aurora, CO | Mina Chung, MD Professor of Medicine Cardiac Pacing and Electrophysiology Department of Cardiovascular Medicine, Heart and Vascular Institute Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute Cleveland Clinic Cleveland, OH |
| Peter H. Stone MD Associate Professor of Medicine Harvard Medical School Co-Director, Samuel A. Levine Cardiac Unit Director, Clinical Trials Center Brigham and Women's Hospital | Rebecca T. Hahn MD Professor of Medicine, Columbia University Director of Interventional Echocardiography The New York Presbyterian Hospital New York, NY |
| Shamir R. Mehta MD Douglas Holder PHRI Endowed Chair in Interventional Cardiology Professor of Medicine McMaster University Director, Interventional Cardiology Hamilton Health Sciences Senior Scientist Population Health Research Institute Hamilton, Canada | Sonia Anand, MD Professor of Medicine and Epidemiology McMaster University Hamilton, Ontario, Canada |
| Sripal Bangalore, MD Professor, Department of Medicine at NYU Grossman School of Medicine Director of Research, Cardiac Catheterization Lab Director, Cardiac Catheterization Laboratory, Bellevue Hospital New York, NY | Tracy Y. Wang, MD Associate Professor Director, Health Services Research Duke University Durham, NC |
| William E. Boden, MD Professor Boston University School of Medicine Dept of Medicine Cardiovascular Medicine | Andrew Cluckey, MD Interventional Cardiology Fellow Vanderbilt University Medical Center Nashville, TN |
| Kyle R. Lehenbauer, MD Fellow Columbia University |
ESTIMATED TIME TO COMPLETE ACTIVITY
10 hours
EDUCATIONAL GRANT SUPPORT
This activity is supported in part by an educational grant from Medtronic.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 10 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
This is a knowledge-based activity. Universal Activity Numbers (UAN): JA4008162-9999-22-089-H01-P
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 10 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
CONTINUING DIETICIAN EDUCATION
This program offers 10 CPEUs for dieticians.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Faculty
A full listing of faculty disclosures 
can be downloaded here.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION & REQUEST FOR CREDIT
There are no registration fees for this activity. During the period March 2, 2022 through March 2, 2023, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at [email protected].
For questions about the accreditation of this activity, please visit www.pimed.com.
For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.
Available Credit
- 10.00 ACPE Pharmacy
- 10.00 AMA PRA Category 1 Credit™
- 10.00 ANCC
- 10.00 CDE
- 10.00 Participation
There are no registration fees for this activity. Please enroll and proceed with the course instructions.
Required Hardware/software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.